Cargando…
Creutzfeldt‐Jakob disease with neuroleptic malignant syndrome
Creutzfeldt‐Jakob disease (CJD) is a rare rapidly progressive fatal neurodegenerative disease. Neuroleptic malignant syndrome (NMS) is a complication of antipsychotic medications which may be used to treat neuropsychiatric symptoms of CJD. We present a case of a 51‐year‐ old woman with CJD who devel...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385257/ https://www.ncbi.nlm.nih.gov/pubmed/34466255 http://dx.doi.org/10.1002/ccr3.4699 |
_version_ | 1783742056058847232 |
---|---|
author | Čiauškaitė, Julija Puleikytė, Ieva Jesmanas, Simonas Jurkevičienė, Giedrė Vaitkus, Antanas Rastenytė, Daiva |
author_facet | Čiauškaitė, Julija Puleikytė, Ieva Jesmanas, Simonas Jurkevičienė, Giedrė Vaitkus, Antanas Rastenytė, Daiva |
author_sort | Čiauškaitė, Julija |
collection | PubMed |
description | Creutzfeldt‐Jakob disease (CJD) is a rare rapidly progressive fatal neurodegenerative disease. Neuroleptic malignant syndrome (NMS) is a complication of antipsychotic medications which may be used to treat neuropsychiatric symptoms of CJD. We present a case of a 51‐year‐ old woman with CJD who developed NMS after being prescribed quetiapine. |
format | Online Article Text |
id | pubmed-8385257 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83852572021-08-30 Creutzfeldt‐Jakob disease with neuroleptic malignant syndrome Čiauškaitė, Julija Puleikytė, Ieva Jesmanas, Simonas Jurkevičienė, Giedrė Vaitkus, Antanas Rastenytė, Daiva Clin Case Rep Case Report Creutzfeldt‐Jakob disease (CJD) is a rare rapidly progressive fatal neurodegenerative disease. Neuroleptic malignant syndrome (NMS) is a complication of antipsychotic medications which may be used to treat neuropsychiatric symptoms of CJD. We present a case of a 51‐year‐ old woman with CJD who developed NMS after being prescribed quetiapine. John Wiley and Sons Inc. 2021-08-24 /pmc/articles/PMC8385257/ /pubmed/34466255 http://dx.doi.org/10.1002/ccr3.4699 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Case Report Čiauškaitė, Julija Puleikytė, Ieva Jesmanas, Simonas Jurkevičienė, Giedrė Vaitkus, Antanas Rastenytė, Daiva Creutzfeldt‐Jakob disease with neuroleptic malignant syndrome |
title | Creutzfeldt‐Jakob disease with neuroleptic malignant syndrome |
title_full | Creutzfeldt‐Jakob disease with neuroleptic malignant syndrome |
title_fullStr | Creutzfeldt‐Jakob disease with neuroleptic malignant syndrome |
title_full_unstemmed | Creutzfeldt‐Jakob disease with neuroleptic malignant syndrome |
title_short | Creutzfeldt‐Jakob disease with neuroleptic malignant syndrome |
title_sort | creutzfeldt‐jakob disease with neuroleptic malignant syndrome |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385257/ https://www.ncbi.nlm.nih.gov/pubmed/34466255 http://dx.doi.org/10.1002/ccr3.4699 |
work_keys_str_mv | AT ciauskaitejulija creutzfeldtjakobdiseasewithneurolepticmalignantsyndrome AT puleikyteieva creutzfeldtjakobdiseasewithneurolepticmalignantsyndrome AT jesmanassimonas creutzfeldtjakobdiseasewithneurolepticmalignantsyndrome AT jurkevicienegiedre creutzfeldtjakobdiseasewithneurolepticmalignantsyndrome AT vaitkusantanas creutzfeldtjakobdiseasewithneurolepticmalignantsyndrome AT rastenytedaiva creutzfeldtjakobdiseasewithneurolepticmalignantsyndrome |